Hormone health
By Dr. K.D. LanierAugust 23, 2026 · Reviewed for public release · IDR-HOR-005
The treatment depends on the diagnosis
Menopause care may involve estrogen, a progestogen, or nonhormonal options. Testosterone therapy for men requires appropriate symptoms, evaluation, and monitoring. Thyroid hormone treats thyroid disease. These therapies are not interchangeable, even when marketing places them under the same umbrella.
FDA-approved and compounded products differ
FDA-approved hormone products include formulations that are chemically identical to hormones made by the body. Custom compounding may be appropriate when an approved product cannot meet a specific clinical need, such as an allergy to an inactive ingredient or a required dosage form. Compounded drugs do not undergo FDA approval, and their safety, effectiveness, and quality are not reviewed before marketing.
Monitoring is part of the treatment
Follow-up should review symptoms, side effects, dose, preventive care, and relevant measurements. The details vary by therapy. More hormone is not automatically better, and a laboratory target should not outrank how the treatment affects your health.
Seek prompt medical guidance for symptoms your clinician identifies as urgent, which may include chest pain, shortness of breath, one-sided leg swelling, sudden neurologic symptoms, severe headache, or unexpected bleeding, depending on your therapy and health history.
Bring these questions to your consultation
At IDARA Truforme, hormone care begins with the person, proceeds through evidence, and stays accountable to follow-up. You should know what is being treated and why.
Educational content only. It does not replace personal medical care.
- What diagnosis and symptom are we treating?
- What evidence supports this product for me?
- What are the alternatives?
- Is it FDA-approved or compounded?
- What personal risks apply?
- When and how will we reassess?
Evidence and review notes
These sources support the educational context and were reviewed for this public educational release. They do not determine individual candidacy, service availability, or treatment recommendations.


